Observational studyClinical drug investigation2023

A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study.

Haiyi Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.